Objective
Natural substances and plant extracts are increasingly important components in the cosmetic and pharmaceutical industry as well as in the wellness sector thanks to its inherent characteristics and their high acceptance among the consumers. Therefore, the market share of natural products has been growing very fast, and for instance plant based drugs represent today a market share of approx. 30 % of Pharmaceuticals. Aloe vera is benefiting of this demand on natural ingredients thanks to its unique healing an d nutritional characteristics: The Aloe vera leaf contains over 75 nutrients and 200 active compounds, including 20 minerals, 18 amino acids, and 12 vitamins and works effectively against sunburn and UV irradiation.
However, up to now no objective method f or quality demonstration and assessment of Aloe Vera has been established, which affects the competitiveness of European producers since they can only compete against imported raw material through offering a higher quality product. The companies of the consortium consider that an European project is the best mean to perform the necessary study and development to establish the regulations and standards that will guaranty their permanence in market keeping to their current product quality.
The AMAY project ai ms at obtaining:
- Exchange of best practises for plantations (maximising yield) regarding soil quality, cultivation methods, plant cultivars
- Isolation and Quantification of Aloverose by NMR (irregularly acetylated polymer of Mannose)
- Development and testing of new products with standardised content of effective compound
Fields of science
Call for proposal
FP6-2002-SME-1
See other projects for this call
Funding Scheme
Data not availableCoordinator
HAMBURG
Germany